Cancer Risk in Primary Sclerosing Cholangitis: Epidemiology, Prevention, and Surveillance Strategies

How Can I Help You?

< All Topics

Cancer Risk in Primary Sclerosing Cholangitis: Epidemiology, Prevention, and Surveillance Strategies

This research paper provides a helpful overview of the various types of cancers PSC patients are at risk of developing, as well as ways to screen for cancer.

The cancers discussed in this paper are cholangiocarcinoma, gallbladder cancer, hepatocellular carcinoma, pancreatic cancer, and colorectal cancer. Screening methods covered in this paper include MRIs/MRCPs, CA 19-9 blood work, ERCPs, and abdominal ultrasounds.

This paper also mentions oral vancomycin! It states that, although there’s no data about oral vancomycin preventing cancer, the therapy has been found to result in significant improvement of clinical symptoms and liver biochemistries in some PSC-IBD patients.

Table of Contents